Menu
Plastic & Reconstructive Surgery

Keloid Scar

ICD-10 Code
L91.0

Plastic & Reconstructive Criteria for Keloid Scar.

Clinical Presentation & Protocol

Patient Usually Complains Of

Patient presents for evaluation of a raised, firm, pruritic skin lesion at the site of a prior [surgical incision/laceration/piercing]. The lesion has progressively enlarged beyond the original wound margins. Patient reports associated symptoms of pain, tenderness, and persistent itching. No history of spontaneous regression.

Clinical Examination Findings

Physical examination reveals a well-defined, firm, erythematous to hyperpigmented nodular plaque. The lesion exhibits a smooth, shiny surface and extends beyond the boundaries of the original trauma site. Texture is indurated and rubbery upon palpation. No signs of secondary infection or ulceration noted.

Treatment Protocol

Recommended management plan: Intralesional corticosteroid injections (e.g., Triamcinolone acetonide) to reduce inflammation and collagen synthesis. Adjunctive therapies include silicone gel sheeting or pressure garments. Surgical excision may be considered if combined with adjuvant radiotherapy or post-operative steroid therapy to minimize recurrence risk.

Keloid Scar: A Comprehensive Medical SEO Guide

1. Executive Overview: Understanding Keloid Scars

Keloid scars are a significant dermatological concern, representing an overgrowth of scar tissue that extends beyond the boundaries of the original skin injury. Unlike hypertrophic scars, which are raised but confined to the wound site, keloids are characterized by their aggressive, expansive growth. This condition, classified under ICD-10 code L91.0, falls within the purview of Plastic and Reconstructive Surgery, a specialty dedicated to restoring form and function.

Keloids are more than just an aesthetic nuisance; they can cause discomfort, itching, pain, and even functional limitations, depending on their location and size. Their development is a complex biological process, often influenced by a combination of genetic predisposition and environmental factors. While the exact mechanisms are not fully elucidated, they involve dysregulation in the wound healing cascade, particularly in collagen synthesis and degradation.

This guide aims to provide a comprehensive, authoritative overview of keloid scars, covering their etiology, pathophysiology, clinical presentation, diagnostic approaches, and the spectrum of therapeutic interventions available. We will delve into the standard of care treatments, including pharmacotherapy, surgical techniques, and adjunctive therapies, as well as discuss the long-term prognosis and management strategies. For individuals seeking information on keloid scars, this guide offers in-depth clinical insights from the perspective of plastic and reconstructive surgery specialists.

2. Detailed Pathophysiology, Etiology, and Risk Factors

The development of a keloid scar is a deviation from the normal wound healing process. Typically, wound healing involves a well-orchestrated sequence of inflammation, proliferation, and remodeling phases. In keloid formation, this process becomes dysregulated, leading to excessive deposition of extracellular matrix, primarily collagen.

Pathophysiology: A Dysregulated Healing Cascade

The core of keloid pathophysiology lies in an imbalance between collagen synthesis and degradation. Key cellular players include fibroblasts, myofibroblasts, and inflammatory cells.

  • Fibroblast Hyperactivity: Fibroblasts in keloid tissue exhibit increased proliferation and a heightened capacity to produce collagen. This leads to an accumulation of collagen type I and III, which are the primary structural proteins in scar tissue.
  • Growth Factor Imbalance: Several growth factors play a crucial role. Transforming growth factor-beta (TGF-β) is heavily implicated, promoting fibroblast proliferation and collagen synthesis. Epidermal growth factor (EGF) and platelet-derived growth factor (PDGF) also contribute. Conversely, factors that promote collagen degradation, such as matrix metalloproteinases (MMPs), may be downregulated or inhibited.
  • Inflammatory Component: While inflammation is a necessary part of wound healing, a persistent or exaggerated inflammatory response in keloid formation can perpetuate fibroblast activity and collagen deposition. Mast cells, often found in abundance in keloid tissue, release histamine and other mediators that can further stimulate fibroblast proliferation.
  • Extracellular Matrix (ECM) Accumulation: The result is a dense, disorganized deposition of collagen, glycosaminoglycans, and other ECM components. This leads to the characteristic raised, firm appearance of a keloid.

Etiology: The Genesis of Keloid Scars

The precise cause of keloid formation is multifactorial, with no single identifiable trigger in all cases. However, it is consistently associated with skin injury.

  • Skin Injury: Any form of skin trauma can potentially lead to keloid formation. Common inciting events include:
    • Surgical incisions (especially those perpendicular to skin tension lines)
    • Burns
    • Acne (particularly severe cystic acne)
    • Insect bites
    • Vaccination sites
    • Piercings
    • Minor abrasions or scratches
  • Genetic Predisposition: A strong genetic component is recognized. Individuals with a family history of keloids are significantly more likely to develop them. Certain genetic markers and polymorphisms are being investigated for their association with keloid susceptibility.
  • Hormonal Influences: Hormonal factors, particularly during periods of hormonal fluctuation, may play a role. Keloids are more common in women, and their incidence peaks during the second and third decades of life. Pregnancy has also been associated with keloid development or exacerbation.

Risk Factors: Who is More Susceptible?

Several factors increase an individual's risk of developing keloid scars:

  • Genetics and Family History: As mentioned, a positive family history is a major risk factor.
  • Age: Keloids are most common in individuals between the ages of 10 and 30 years. They are less common in young children and the elderly.
  • Race/Ethnicity: Individuals with darker skin tones (e.g., those of African, Asian, or Hispanic descent) have a higher incidence of keloid formation compared to individuals with lighter skin. This is thought to be related to differences in melanocyte function and inflammatory responses.
  • Location of Injury: Certain areas of the body are more prone to keloid development, including the chest, shoulders, upper back, earlobes, and sternal area. These areas may have higher skin tension or different inflammatory responses.
  • Type of Injury: Deep wounds, burns, and injuries that involve tension on the wound edges are more likely to result in keloids.

3. Signs, Symptoms, and Clinical Presentation

The clinical presentation of a keloid scar is distinct and can vary in size, shape, and color.

Physical Characteristics:

  • Raised and Firm: Keloids are palpable, raised lesions that feel firm and often rubbery or hard to the touch.
  • Extends Beyond Original Wound: This is a hallmark feature differentiating keloids from hypertrophic scars. The scar tissue grows outwards, invading the surrounding normal skin.
  • Irregular Shape: Keloids often have an irregular, lobulated, or multinodular appearance. They can grow in various patterns, including linear, nodular, or even assume a "crab claw" configuration.
  • Color: Initially, keloids may appear erythematous (red or pink) due to increased vascularity. Over time, they tend to become flesh-colored, hypopigmented, or hyperpigmented, contrasting with the surrounding skin.
  • Variable Size: Keloids can range from small, discrete nodules to large, disfiguring masses that can cover significant portions of the body.

Associated Symptoms:

While primarily a cosmetic concern, keloids can also be associated with bothersome symptoms:

  • Itching (Pruritus): This is a very common symptom, often intense and persistent, leading to significant patient distress.
  • Pain and Tenderness: Some keloids can be painful or tender to the touch, especially if they are irritated or inflamed.
  • Burning Sensation: A burning sensation may also be reported.
  • Restricted Movement: Large keloids, particularly those located over joints or in areas of skin mobility, can cause tightness and restrict normal movement. This is especially true for keloids resulting from burns.

Differential Diagnosis: Distinguishing from Hypertrophic Scars

It is crucial to differentiate keloids from hypertrophic scars, as their management and prognosis differ.

Feature Keloid Scar Hypertrophic Scar
Growth Pattern Extends beyond original wound boundaries Confined to the original wound boundaries
Onset Can appear months to years after injury Typically appears within weeks to months
Regression Does not regress spontaneously May regress partially over time
Recurrence High recurrence rate after excision Lower recurrence rate after excision
Cause Genetic predisposition, any skin injury Often associated with significant trauma/tension
Appearance Often irregular, nodular, sometimes "claw-like" Raised, firm, linear, follows wound pattern

4. Standard Diagnostic Evaluation & Workup

The diagnosis of a keloid scar is primarily a clinical one, based on its characteristic appearance and history. Laboratory tests and imaging are generally not required for diagnosis but may be used in specific circumstances or for ruling out other conditions.

Clinical Examination: The Gold Standard

The gold standard for diagnosing a keloid scar is a thorough clinical evaluation by a qualified medical professional, typically a dermatologist or plastic surgeon. This involves:

  • Patient History: Gathering detailed information about the onset of the scar, its evolution, any preceding injury, family history of keloids, and associated symptoms (itching, pain).
  • Physical Examination: Careful inspection of the lesion, noting its size, shape, color, texture, and whether it extends beyond the original wound margins. Palpation to assess firmness and tenderness.
  • Differentiating from Hypertrophic Scars: The clinician will meticulously assess the growth pattern and compare it to the original wound.

Imaging Studies: Rarely Indicated

  • Ultrasound: In rare cases, ultrasound might be used to assess the depth and vascularity of a lesion, particularly if there is diagnostic uncertainty. However, it is not a routine diagnostic tool for keloids.
  • Other Imaging (MRI, CT): These are generally not indicated for the diagnosis of keloid scars themselves. They might be employed if a keloid is suspected to be causing significant mass effect or pressing on adjacent structures, but this is uncommon.

Laboratory Assays: Supportive Role

  • No specific blood tests are used to diagnose keloid scars.
  • Biopsy: A skin biopsy is considered the definitive diagnostic test if there is any doubt regarding the diagnosis or if the lesion is atypical. It allows for histological examination of the scar tissue.

Histopathological Examination (Biopsy)

A skin biopsy provides crucial information for confirming the diagnosis and understanding the underlying tissue changes. Histological findings in keloids typically include:

  • Dense, haphazardly arranged collagen bundles: These are often thick and hyalinized.
  • Increased fibroblast proliferation: More fibroblasts are present than in normal scar tissue.
  • Abnormal elastic fibers: There may be fragmentation or disorganized arrangement of elastic fibers.
  • Increased vascularity: Prominent blood vessels, often dilated, are present.
  • Inflammatory infiltrate: Presence of inflammatory cells, particularly mast cells.

The biopsy is typically performed under local anesthesia. The specimen is sent to a pathology laboratory for microscopic examination. While not always necessary for a straightforward clinical diagnosis, it is invaluable in complex cases or for research purposes.

5. Therapeutic Interventions: A Multimodal Approach

The management of keloid scars is often challenging due to their tendency to recur and the subjective nature of treatment outcomes. A multimodal approach, often combining several treatment modalities, is frequently employed to achieve the best results. The goal is to flatten the scar, reduce symptoms, and prevent recurrence.

Pharmacotherapy

Medications play a significant role in both topical and injectable forms.

  • Corticosteroids (Intralesional Injections):
    • Mechanism: Anti-inflammatory and anti-fibrotic properties, reducing collagen synthesis and inflammation.
    • Application: Triamcinolone acetonide is the most commonly used corticosteroid. Injections are administered directly into the keloid tissue.
    • Efficacy: Often the first-line treatment for symptomatic keloids, leading to flattening and reduction in itching and pain. Multiple sessions are usually required.
    • Side Effects: Local skin atrophy, hypopigmentation, telangiectasias.
  • 5-Fluorouracil (5-FU) (Intralesional Injections):
    • Mechanism: Antimetabolite that inhibits DNA synthesis, thus reducing fibroblast proliferation.
    • Application: Can be used alone or in combination with corticosteroids.
    • Efficacy: Effective in reducing the size and symptoms of keloids.
    • Side Effects: Local irritation, pain, transient skin discoloration.
  • Bleomycin (Intralesional Injections):
    • Mechanism: An antineoplastic agent that inhibits collagen synthesis.
    • Application: Used for recalcitrant keloids, often in combination with other therapies.
    • Efficacy: Can lead to significant flattening.
    • Side Effects: Pain, hyperpigmentation, potential for ulceration.
  • Topical Agents:
    • Silicone Gel Sheets/Liquids: Applied directly to the scar, they help to hydrate the scar tissue, reduce collagen synthesis, and decrease fibroblast proliferation. They are particularly useful for preventing keloid formation in high-risk individuals and for managing existing scars.
    • Onion Extract Preparations: Some topical preparations containing onion extract have shown mild efficacy in reducing inflammation and softening scars.
    • Corticosteroid Creams: Less effective than intralesional injections but may offer some benefit for smaller, less severe keloids.

Surgical Interventions

Surgical excision of keloids is often considered when other treatments fail or for very large, disfiguring keloids. However, it carries a high risk of recurrence, often resulting in even larger keloids.

  • Excision: The keloid is surgically removed.
    • Techniques: Various techniques exist, including simple elliptical excision, W-plasty, or Z-plasty to minimize wound tension.
    • Post-operative Management: Crucially, adjuvant therapies are almost always recommended immediately after surgery to prevent recurrence. This commonly includes:
      • Radiation Therapy (Brachytherapy or External Beam): Often delivered within 24-48 hours of surgery, radiation significantly reduces the risk of recurrence by inhibiting fibroblast proliferation.
      • Corticosteroid Injections: Initiated post-operatively.
      • Silicone Gel Sheets: Continued application.
  • Cryotherapy:
    • Mechanism: Freezing the keloid tissue with liquid nitrogen, causing cellular destruction and reducing inflammation.
    • Application: Can be used as a standalone treatment for smaller keloids or in combination with intralesional corticosteroids.
    • Efficacy: Can lead to flattening and softening.
    • Side Effects: Pain, blistering, hypopigmentation or hyperpigmentation, and potential for ulceration.

Other Therapeutic Modalities

  • Radiation Therapy: As mentioned, it is a powerful adjuvant therapy post-excision. It can also be used as a primary treatment for certain keloids, particularly for symptomatic relief.
  • Laser Therapy:
    • Pulsed Dye Laser (PDL): Effective for reducing the redness and improving the texture of keloids by targeting abnormal blood vessels.
    • Fractional Lasers: Can help remodel collagen and improve scar appearance.
  • Pressure Therapy: Applying continuous pressure to the keloid using specialized garments or dressings can help flatten the scar by restricting blood flow and collagen synthesis. This is often used for earlobe keloids and post-surgical keloids.
  • Lifestyle and Prevention:
    • Avoidance of Elective Procedures in High-Risk Areas: Individuals known to develop keloids should exercise caution with piercings and elective surgeries in prone areas.
    • Proper Wound Care: Meticulous wound care, minimizing tension on surgical incisions, and early application of silicone sheets can help prevent keloid formation.

6. Frequently Asked Questions (FAQ) about Keloid Scars

This section addresses some of the most common questions patients have about keloid scars, providing clear and concise answers from a clinical perspective.

Q1: What exactly is a keloid scar, and how is it different from a normal scar?

A keloid scar is an abnormal, excessive growth of scar tissue that extends beyond the original boundaries of a skin injury. Unlike normal scars, which typically heal flat and fade over time, keloids are raised, often firm, and can continue to grow. The key difference is that keloids invade surrounding healthy skin, whereas hypertrophic scars remain confined to the original wound area.

Q2: What causes keloid scars to form?

The exact cause is not fully understood, but it's believed to be a result of a genetic predisposition combined with an abnormal wound healing response. Any skin injury, from minor cuts and burns to surgical incisions, acne, or piercings, can trigger keloid formation in susceptible individuals. Factors like genetics, age, and skin type play a significant role.

Q3: Are certain people more prone to developing keloids?

Yes, certain individuals are more prone. People with darker skin tones (African, Asian, Hispanic descent) have a higher incidence. Keloids are also more common in younger individuals (ages 10-30) and those with a family history of keloids. Certain body areas, like the chest, shoulders, and earlobes, are also more susceptible.

Q4: What are the most effective treatments for keloid scars?

Treatment is often challenging and may require a combination of therapies. First-line treatments commonly include intralesional corticosteroid injections to reduce inflammation and flatten the scar. Other effective options include cryotherapy (freezing), silicone gel sheets or pressure dressings, laser therapy (e.g., pulsed dye laser), and topical medications. Surgical excision is an option but carries a high risk of recurrence and is often combined with radiation therapy or other adjuvant treatments.

Q5: Can keloid scars be completely removed or cured?

While keloid scars can be significantly improved in appearance and symptoms, a complete "cure" or permanent removal without recurrence is difficult to achieve. They have a high tendency to regrow, sometimes even larger than before, especially after surgical removal. The goal of treatment is often to manage the scar, reduce its size and symptoms, and prevent recurrence.

Q6: How long does it take for a keloid scar to stop growing?

There's no set timeline. Some keloids may stop growing after a few months, while others can continue to enlarge for years. The growth rate is highly variable and depends on individual factors and the nature of the original injury.

Q7: Do keloid scars itch or hurt?

Yes, itching (pruritus) is a very common symptom associated with keloid scars and can be quite intense and bothersome. Many people also experience pain, tenderness, or a burning sensation, particularly if the keloid is irritated or inflamed.

Q8: Is surgery the best option for removing a keloid scar?

Surgery alone is often not the best option because of the high risk of recurrence. When surgery is performed, it is almost always combined with other therapies, such as radiation therapy (given shortly after surgery) or intralesional steroid injections, to significantly reduce the chance of the keloid returning.

Q9: Can keloid scars be prevented?

For individuals at high risk (e.g., known keloid formers, those with darker skin), prevention strategies are important. This includes meticulous wound care, minimizing tension on surgical incisions, avoiding elective procedures in prone areas (like earlobe piercings), and using silicone gel sheets or pressure dressings on new wounds or post-surgery.

Q10: How long does treatment for a keloid scar typically take?

Treatment duration varies widely depending on the size, location, and severity of the keloid, as well as the chosen treatment modalities. Intralesional injections may require multiple sessions over several months. Other therapies might involve ongoing management for extended periods. It's crucial to have realistic expectations and work closely with your medical provider for a personalized treatment plan.

This comprehensive guide provides an in-depth understanding of keloid scars from a medical and surgical perspective. If you are concerned about a keloid scar, consulting with a plastic and reconstructive surgeon or a dermatologist is the essential first step towards effective management and treatment.